Is it possible to tell if our infusion pumps are "smart" or not by looking at them from Gerald Bell's blog

It is one of the most common reasons for patient harm in hospitals and operating rooms when medications are administered incorrectly.  According to the American Society of Clinical Pharmacy, more than half of all medication errors that result in patient injury happen during the administration phase of a medication regimen. The majority of human history has been characterized by the use of mechanical infusion devices to administer medications intravenously, which were essentially the same as today.  Smart Syringe Pump have made it possible to integrate clinical decision support tools into the medication administration process, which was previously impossible.  Patients in acute care settings, including the perioperative setting, are increasingly utilizing smart pumps with built-in drug libraries, which are becoming more common.  Currently, DERS is found in virtually all Injection Pump utilized in the acute care setting, including those utilized in the intensive care unit (ICU) and other intensive care units.  When it comes to making decisions, they have the option of bypassing this assistance if they so choose. . . The use of out-of-date interfaces, as well as the ability to opt out of the DERS program with relative ease, are both significant contributors to noncompliance with the DERS program, according to the report. 5                                                        It is necessary to identify the roadblocks that prevent employees from complying with DERS regulations before evaluating the potential impact of smart infusion pump on a company's operations.

Development and maintenance of specialized drug libraries are two separate processes.  When it comes to developing the drug library that will serve as the foundation for DERS limits, it is frequently necessary to start from the beginning of the process.  In this repository, you can find information about the medications that are included in this library, as well as safety alert thresholds for dose and concentration, duration and rate of alerting, and other factors.  These libraries require a significant amount of time and resources to build, which makes them expensive.  It is unfortunate that this time-consuming and resource-intensive process of developing a drug library is only the beginning of the journey ahead of you.  Maintenance and updating of content are critical when it comes to making the most of this technology and getting the most out of it.  Incorrect implementation of smart pumps may cause a stumbling block to the widespread adoption of smart pumps in the future.

It is possible for health-care providers to become alarm or alert fatigue if they receive an excessive number of alerts/alarms.  Smart infusion pumps are no different than any other type of health-care technology when it comes to this problem.  When it comes to drug administration, what kind of information is captured by infusion devices and why?

Data evaluation and compliance with DERS regulations can be accomplished through the use of conventional methodologies.

The DERS is one of the options available to clinicians when programming infusion pumps, and it can be used in conjunction with other options such as programming the pump in a no-drug selected or basic infusion mode.  As a result of the absence of DERS, clinicians are effectively removing all clinical decision support and safety limits from the process altogether.  A majority of infusion pump devices can provide information about the percentage of infusions that were performed using the DERS, and this information is useful.  The frequency with which programming errors occur or the frequency with which DERS is bypassed may be unknown to clinicians until something like this happens to them or to someone they know and trust.  It is critical to share this information with frontline clinicians in order to establish a sufficient feedback loop to support continuous quality improvement and continuous quality improvement.

Information on alerts and alarms can be found here.

In a few studies, the use of smart Injection Pump was linked to alert fatigue as well as severe adverse events in the days following their administration. 6 p.  m.  to 8 p.  m.  Monday through FridayA clinician's deafening deafening deafening deafening Deafening Deafening Deafening Deafening Deafening Deafening Deafening Deafening Deafening Deafening Deafening Deafening Deafenning Deafening Deafening Deafening Deafening DeafenThe numbers from 1 to 18 are 11, 12, 13, 14, 15, 16, 17, and 18.  As a result of the presence of clinically insignificant or obnoxious alerts in the environment, the body becomes desensitized to these stimuli over time.

In clinical alert logs, each alert and the clinician's response are recorded, allowing for more efficient alert management as well as a reduction in clinician fatigue.  The diversion of narcotics away from the criminal justice system is a positive development.

According to the latest recommendations from the American Society of Hospital Physicians (ASHP), hospitals should implement a surveillance program that effectively monitors data from medication technologies in high-risk areas such as the operating room.  It is critical to understand the difference between the amount of medication that is dispensed and the amount of medication that is administered to the patient in order to ensure the success of a narcotic diversion monitoring program.  If fentanyl is administered in a 2500 mcg/250 mL bag, the infusion pump data will record the exact amount of drug administered by the infusion pump, as well as the time at which it was administered, as an example.  It is possible that the unused medication will be diverted, and as a result, it must be recorded in the medical records as "wasted medication. "Controlled substance diversion can be detected by comparing the dispensed volume with the administered and wasted volumes, which can be accomplished through the use of controlled substance diversion monitoring.  According to research, reducing the amount of opioids prescribed in other patient care settings has been associated with a reduction in the number of opioid-related complications.

There is a scarcity of pharmaceuticals in the marketplace.
According to the World Health Organization, drug shortages have unpredictable onsets and have escalated to the level of a national crisis that poses a threat to the health and safety of patients.  Between 2010 and 2018, an average of nearly 1500 new shortages were reported each year, a significant increase from 2010.  According to some estimates, a scarcity of injectable medications on the market is responsible for up to 63% of these shortages.  there are a total of twentyPatients' safety and well-being may be jeopardized in the event of a drug shortage if clinicians are forced to use less familiar alternatives.  The analysis of infusion pump data may be able to provide a more precise measurement of the drugs that patients are receiving and how much is being wasted during a nationwide drug shortage.  This information may prove useful in ensuring the continued availability of pharmaceuticals.